Bortesun

Bortesun Dosage/Direction for Use

bortezomib

Manufacturer:

Sun Pharma

Distributor:

DKLL

Marketer:

Ranbaxy
Full Prescribing Info
Dosage/Direction for Use
For subcutaneous or intravenous use only. Each route of administration has a different reconstituted concentration. Exercise caution when calculating the volume to be administered.
The recommended starting dose of BORTESUN is 1.3 mg/m2 administered either as a 3 to 5 second bolus intravenous injection or subcutaneous injection.
Retreatment for Multiple Myeloma: May retreat starting at the last tolerated dose.
Hepatic Impairment: Use a lower starting dose for patients with moderate or severe hepatic impairment.
Dose must be individualized to prevent overdose.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in